Nomura Initiates Coverage on China's DRAM Leader, Setting 116 Yuan Target on Par with Micron's $1 Trillion Market Cap

Deep News
07/27

Nomura has initiated coverage on China's leading DRAM manufacturer, Cxmt Corporation (688825), on the day of its Shanghai Stock Exchange debut, issuing a "buy" rating and a 12-month price target of 116 yuan per share. This target implies a market capitalization of approximately 7.76 trillion yuan, equating to about $1 trillion, which is in line with the current valuation of U.S. rival Micron Technology (MU).

On July 27, the company's stock surged 531% in morning trading to 54.65 yuan, pushing its total market value past 3.6 trillion yuan. This leap allowed it to overtake Industrial and Commercial Bank of China as the largest company by market cap on the A-share market.

Key Drivers Behind the Aggressive Forecast

Nomura's research report highlights that the tight supply conditions in the memory chip market are unlikely to ease for several years. The investment bank projects that Cxmt's revenue and net profit attributable to shareholders will see compound annual growth rates of 63% and 74%, respectively, between fiscal years 2026 and 2028. This growth is expected to be fueled by capacity expansion, process node migration, and rising average selling prices (ASP).

The 116 yuan target is based on a projected earnings per share (EPS) of 5.8 yuan for fiscal year 2028, applying a target price-to-earnings (P/E) ratio of 20 times. The core of this valuation logic relies on a "dual premium" approach.

Valuation Strategy: A 'Dual Premium' Approach

First, Nomura uses Micron Technology as a comparable benchmark, noting that Micron's P/E ratio has ranged between 5 and 15 times over the past five years, with a median of about 10 times. Nomura predicts Cxmt will command a 2x premium over Micron's valuation, justifying the 20x P/E multiple. Second, the report cites a "China market valuation premium." By comparing semiconductor equipment companies listed in both the U.S. and China, Nomura observes that A-share markets typically grant higher multiples. As the sole publicly traded DRAM stock in China, Cxmt is seen as deserving an additional market premium.

Risk Factors Identified by Nomura

Nomura also outlines four key downside risks to its bullish thesis. These include a deterioration in end-market demand, intensifying competition from domestic peers like unlisted Yangtze Memory Technologies Corp. (YMTC), insufficient supply of integrated circuits and components such as CPUs, and an escalation in geopolitical tensions between the U.S. and China.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10